1. Home
  2. AZIO vs MRKR Comparison

AZIO vs MRKR Comparison

Compare AZIO & MRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AZIO

Azio AI Holdings Inc. Common Stock

N/A

Current Price

$0.53

Market Cap

19.4M

ML Signal

N/A

Logo Marker Therapeutics Inc.

MRKR

Marker Therapeutics Inc.

N/A

Current Price

$0.92

Market Cap

19.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AZIO
MRKR
Founded
2021
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.4M
19.5M
IPO Year
2014
2010

Fundamental Metrics

Financial Performance
Metric
AZIO
MRKR
Price
$0.53
$0.92
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
★ $7.87
AVG Volume (30 Days)
★ 343.4K
182.9K
Earning Date
11-20-2026
11-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 33.61
EPS
★ N/A
N/A
Revenue
★ $5,939,008.00
N/A
Revenue This Year
N/A
$19.61
Revenue Next Year
N/A
$375.85
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 217.58
N/A
52 Week Low
$0.67
$0.84
52 Week High
$1.84
$2.46

Technical Indicators

Market Signals
Indicator
AZIO
MRKR
Relative Strength Index (RSI) 30.26 43.00
Support Level N/A $0.88
Resistance Level $1.45 $1.32
Average True Range (ATR) 0.10 0.11
MACD -0.01 -0.00
Stochastic Oscillator 3.03 11.34

Price Performance

Historical Comparison
AZIO
MRKR

About AZIO Azio AI Holdings Inc. Common Stock

Azio AI Holdings Inc is a technology infrastructure company focused on developing, owning, and operating artificial intelligence data centers, enterprise GPU compute infrastructure, digital power solutions, and digital asset mining operations. The company operates an integrated AI infrastructure business encompassing AI data center development, the sale and distribution of enterprise GPU systems and server infrastructure, high-performance computing solutions, power hosting, and strategic technology investments, serving enterprise and institutional customers across domestic and international markets.

About MRKR Marker Therapeutics Inc.

Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from MAR-T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells. These T cells are designed to recognize multiple tumor targets to produce broad spectrum anti-tumor activity. Its pipeline products include: Autologous MAR-T cell product for the treatment of lymphoma and pancreatic cancer (MT-601), and Off-the-Shelf (OTS) products (MT-401-OTS).

Share on Social Networks: